An initiative that brings together experts in cardiovascular and immune-mediated inflammatory diseases across 30 centres in the UK.
See Our CentresOur mission is to transform the management of cardiovascular involvement of people with IMIDs through better understanding of inflammation science of cardiovascular disease, enhanced diagnostics and monitoring and precision therapeutics. This will be achieved by establishing a world class patient-centred, dynamic and sustainable, collaborative UK infrastructure in cardio-rheumatology to conduct scalable experimental medicine research and targeted therapeutic trials.
The UK CARDIO-IMID Partnership is the first national network of inter-disciplinary rheumatology and cardiovascular clinicians, clinician scientists and basic scientists that wish to address the unmet needs of people with IMIDs and cardiovascular involvement and thereby improve outcomes of people with IMIDs and the wider population.
We initially developed a UK network of cardiovascular and rheumatology clinicians and researchers from 30 centres across the UK with the support of the National Institute of Health and Care Research (NIHR)-British Heart Foundation (BHF) Cardiovascular . With Medical Research Council and British Heart Foundation (BHF) co-funding awarded in 2023, we have established the UK CARDIO-IMID Partnership.
Working across this national network that reaches all devolved nations, the UK CARDIO-IMID Partnership will strengthen collaborations to support training and education in cardio-rheumatology, sharing of best practice and development and delivery of high-quality biomedical research studies.
We are an inclusive working group and welcome investigators with ideas for collaborative education and research efforts at the intersection of inflammatory and cardiovascular diseases.
We are pleased to announce release of the first publication from the UK CARDIO-IMID Partnership. In this Nature Reviews Rheumatology article, authored by our core investigators, we summarise current concepts on the potentially targetable inflammatory mechanisms of cardiovascular pathology in rheumatic IMIDs and discuss how these concepts can be considered for the diagnosis and management […]
Read MoreA key aim of the Partnership is to connect leading cardiovascular and immunology researchers and institutions across the UK to generate novel collaborative research projects and increase the profile of CARDIO-IMID in the UK healthcare sector. Our current participating centres can be viewed in the infographic below.
